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https://doi.org/10.1016/j.stemcr.2019.09.003The environment surrounding stem cells has the ability to elicit
profound, heritable epigenetic changes orchestrated by multiple
epigenetic mechanisms, which can be modulated by the level of
specific metabolites. In this review, we highlight the significance
of metabolism in regulating stem cell homeostasis, cell state, and
differentiation capacity, using metabolic regulation of embryonic
and adultmuscle stemcells as examples, and cast light on the inter-
action between cellular metabolism and epigenetics. These new
regulatory networks, based on the dynamic interplay between
metabolism and epigenetics in stem cell biology, are important,
not only for understanding tissue homeostasis, but to determine
in vitro culture conditions which accurately support normal cell
physiology.
Basic Features of Embryonic and Adult Stem Cells
As a result of their ability to self-renew and to differentiate
into different cell types, stem cells play critical roles in
development and tissue homeostasis. Both embryonic
stem cells (ESCs) and adult stem cells (ASCs) are affected
by intrinsic and extrinsic signals, which regulate their
self-renewal capacity and the balance between stem cell po-
tency and differentiation (Jaenisch and Young, 2008).
The totipotent cleavage-stage preimplantation embryo
gives rise to the blastocyst, within which the inner cell
mass (ICM) is representative of a transient, highly prolifer-
ative pluripotent cell population from which ESCs are
derived. In response to local cues, the pluripotent ICM un-
dergoes lineage specification toward each of the three germ
layers, progressively differentiating into more specialized
cell types. A number of pluripotent states have been
described in vivo and in vitro (reviewed by Davidson et al.,
2015), underpinned by differing growth factor and
signaling pathway requirements. Self-renewal and mainte-
nance of pluripotency of mouse ESCs relies on leukemia
inhibitory factor (LIF) (Brook and Gardner, 1997), whereas
human ESCs, derived from a later ‘‘primed’’ pluripotent cell
population likely representative of post-implantation
epiblast, rely on activin/Nodal and fibroblast growth factor
(FGF) signaling (Vallier et al., 2005). Alternatively, a more
naive pluripotent state can be achieved in culture through
the inhibition of signaling pathways that regulate differen-
tiation (Ying et al., 2008; Zimmerlin et al., 2017). Thus,Stem Cell R
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the three germ lineages.
In contrast to the high proliferation rates of ESCs, ASCs
generally exist in a quiescent state where transient cell-cy-
cle inhibition prevents exhaustion of the stem cell pool (Ito
and Suda, 2014). However, in contrast to pluripotent ESCs,
most ASCs are lineage restricted, therefore multipotent,
maintaining tissue homeostasis, responding to damage
and/or stress. Depending on the tissues, certain ASCs
display extensive plasticity and can give rise to different
specialized cell types in different organs (Raff, 2003),
whereas other ASCs exhibit more restricted plasticity (Wa-
gers and Weissman, 2004). ASCs reside within specialized
niches which provide specific cues, including stromal cells,
extracellular matrix (ECM), vascularization, and innerva-
tion that support their capacity for self-renewal (Jones
and Wagers, 2008). ASCs can divide either symmetrically,
thereby producing two identical cells that replicate and
expand in number, or asymmetrically, thereby producing
one identical and one committed stem cell, depending
on developmental and environmental signals. Upon
recruitment, or in certain pathological conditions, ASCs
exit from their quiescent state, re-enter the cell cycle, pro-
liferate, and commit to and differentiate into specific tissue
lineages. Most ASCs have the ability to switch between
asymmetric and symmetric division, and an imbalance be-
tween the two modalities is often associated with disease
states.
Muscle stem cells (MuSCs), or satellite cells, are ASCs
located between the basal lamina and the sarcolemma of
muscle fibers and are crucial for skeletal muscle growth
and regeneration (Comai and Tajbakhsh, 2014). Whereas
MuSC activation and proliferation rely on Notch activity
(Conboy et al., 2003), the commitment and onset of differ-
entiation is due to a transition from Notch to Wnt
signaling, the latter being an important regulator of termi-
nal differentiation (Brack et al., 2008). Several growth fac-
tors in the satellite cell niche affect MuSCs, in part by influ-
encing the temporal transition from Notch to Wnt
signaling. FGF, hepatocyte growth factor, and platelet-
derived growth factor promote activation and proliferationeports j Vol. 13 j 573–589 j October 8, 2019 j ª 2019 The Authors. 573
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MuSC differentiation is primarily promoted by the insu-
lin-like growth factor 1 but severely inhibited by transform-
ing growth factor b family members (Kuang et al., 2008).
However, while growth factors, cytokines, and the ECM
have traditionally been considered as the signals that
regulate cell decisions through pathway activation, it is
now becoming increasingly apparent that metabolites
can also act as signaling molecules, interacting with their
own receptors and regulating a vast array of cellular func-
tions. Increasing evidence supports a role for metabolism
in regulating the complexity of early development and
lineage specification.
Metabolic Control of Stem Cells
Metabolism underpins cell function, with coordinated
nutrient utilization necessary to maintain homeostasis,
including cellular energy (ATP) production and biosyn-
thesis to support proliferation (Metallo andVander Heiden,
2013). Cell function and the surrounding nutrient micro-
environment determine cellular metabolic requirements,
which are supported by the activity of coremetabolic path-
ways, including glycolysis, the pentose phosphate
pathway, the tricarboxylic acid (TCA) cycle and oxidative
phosphorylation (OXPHOS), which enable adaptation to
nutrient availability. This flexibility promotes cell and or-
ganism survival, and supports dynamic, stage-specific en-
ergy demands through development. However, long-term
adaptation contributes to altered cell health, as demon-
strated by numerous diseases characterized by perturba-
tions in metabolism (Cai et al., 2012; Perl, 2017; Wallace,
2012). Consequently, once considered mere by-products
of energy production, metabolites are increasingly recog-
nized for their diverse roles in mediating cell signaling,
with emerging evidence from stem cells implicatingmetab-
olites in the regulation of self-renewal, differentiation, and
cell state.
Changing Metabolic Demands during Early Development
The transition of the early preimplantation embryo
through differentiation is accompanied by changing en-
ergy requirements that require dynamic, coordinated regu-
lation of metabolism to support ongoing development.
Although oocytes are unable to utilize glucose during
in vitromaturation, they preferentiallymetabolize pyruvate
via OXPHOS, supported through the glycolytic activity of
the surrounding cumulus cells (Dumesic et al., 2015). Simi-
larly, the early pre-compaction embryo exhibits low levels
of oxidative metabolism and oxygen consumption, utiliz-
ing pyruvate, lactate, and amino acids (Gardner and Har-
vey, 2015). With the activation of the embryonic genome,
ICM and trophectoderm specification, and the energy
requirement to support blastocoel formation, the blasto-
cyst stage embryo increases its requirement for glucose;574 Stem Cell Reports j Vol. 13 j 573–589 j October 8, 2019however, it maintains a high level of oxygen consumption.
Indeed, the ICM is predominantly glycolytic, while the
trophectoderm is more oxidative (Hewitson and Leese,
1993). Significantly, these metabolic changes coincide
with migration of the embryo from the oviduct to the
uterus, accompanied by changes in the nutrient composi-
tion of reproductive tract fluid (Gardner et al., 1996),
including a reduction in oxygen availability from 7% to
2% (Fischer and Bavister, 1993).
The glycolytic metabolic state of the pluripotent ICM is
replicated in vitro, whereby ESCs rely on aerobic glycolysis
to support biosynthesis (Harvey et al., 2016a), even in the
presence of sufficient oxygen, termed the Warburg effect
(Harvey et al., 2013). Furthermore, the transition between
naive and primed pluripotency is accompanied by changes
in metabolism, whereby naive mouse ESCs exhibit lower
rates of glycolysis compared with primed ESCs, accompa-
nied by upregulation of oxidative metabolism (Zhou
et al., 2012). In contrast, cultured naive human ESCs
exhibit both upregulation of OXPHOS and increased
glycolysis relative to their primed counterparts (Gu et al.,
2016), suggesting that differing metabolic profiles likely
reflect different cell states within pluripotency. However,
these divergentmetabolic statesmay also reflect differences
in medium composition (and hence relative metabolite
levels) and culture conditions (Zhang et al., 2016a). Indeed,
the availability of metabolites has been shown to impact
the balance between pluripotency and differentiation and
is important for the maintenance of cell state.
Glucose and glutamine availability regulate self-renewal
in culturedmouse and human ESCs, through the provision
of acetyl-CoA and alpha-ketoglutarate (aKG) (Carey et al.,
2015; Moussaieff et al., 2015). Unlike primed mouse
ESCs, naive mouse ESCs are not dependent on glutamine
to maintain proliferation; however, they utilize both
glucose and glutamine to maintain self-renewal by main-
taining high levels of intracellular aKG (Carey et al.,
2015). In support of this, aKG can replace 2i/LIF to sustain
naive pluripotency and prevent the transition to a more
primed cell state (Tischler et al., 2019). Equally, a require-
ment for acetyl-CoA is demonstrated by supplementation
with dichloroacetate to increase the conversion of pyru-
vate to acetyl-CoA, which supports the mouse naive cell
state (Tischler et al., 2019). Human ESC self-renewal is simi-
larly supported by high rates of glycolysis that support
acetyl-CoA production (Moussaieff et al., 2015), such that
inhibition of glycolysis with 2-deoxyglucose leads to ESC
differentiation in vitro, which can be reversed through
supplementation of acetate (Carey et al., 2015). Signifi-
cantly, high glucose has been shown to suppress human
ESC-derived cardiomyocyte differentiation and conse-
quently cardiac maturation (Nakano et al., 2017). In
contrast, cardiomyocyte differentiation can be enhanced
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These findings are particularly significant, given that the
vast majority of media to support both self-renewal and
differentiation contain high glucose levels which may
interfere with differentiation, purity, and cell function
and maturation.
Interestingly, whereas inhibition of glycolysis with 2-de-
oxyglucose in serum/LIF-cultured mouse ESCs leads to dif-
ferentiation (Kondoh et al., 2007) similar to that seen in hu-
manESCs, inhibition innaivemouse ESCshas recently been
shown to impede the exit from naive pluripotency (Tischler
et al., 2019), suggesting temporal differences inmetabolic re-
quirements across pluripotent cell states. Significantly,while
oxygen availability does not apparently alter ESC pluripo-
tency at the molecular level, physiological conditions (5%
oxygen; which replicate the in vivo environment) increase
glycolytic activity (Harvey et al., 2016b; Lees et al., 2019).
Physiological oxygen conditions are also likely to maintain
high levels of aKG and acetyl-CoA to underpin cell state.
Consequently, the use of atmospheric oxygen conditions
will not onlymodulate nutrient flux, and epigeneticmodifi-
cations, as has been observed in human ESCs (Lees et al.,
2019), but is likely to alter cellular responses to other
nutrient changes, plausibly modifying lineage decisions,
including kinetics. Therefore, it is important to acknowledge
that the majority of studies on metabolic control of stem
cells have been performed under 20% oxygen.
Similarly, threonine andmethionine, through the gener-
ation of S-adenosylmethionine (SAM), are critical formain-
taining mouse and human ESC self-renewal, respectively.
Threonine dehydrogenase (TDH) is the rate-limiting
enzyme for threonine catabolism, converting threonine
to acetyl-CoA and glycine, the latter available for SAM
generation via the folate cycle. TDH is highly expressed
in proliferating mouse ESCs and decreases upon differenti-
ation to embryoid bodies (Wang et al., 2009). Significantly,
threonine deprivation reduces mouse ESC proliferation
and increases their differentiation in vitro (Wang et al.,
2009), accompanied by reduced SAM accumulation, lead-
ing to altered differentiation potential (Shyh-Chang
et al., 2013). Human cells lack the ability to use threonine;
however, methionine is likewise important for cultured
human ESC survival through the generation of SAM,
with short-term methionine deprivation potentiating
human ESC differentiation (Shiraki et al., 2014), suggesting
a role for metabolites in lineage specification. In support of
this, the presence of proline in the growth medium has
been shown to induce mouse ESC differentiation (Wash-
ington et al., 2010), and may be required for lineage speci-
fication within the developing embryo in vivo (Tan et al.,
2016).
The exit from pluripotency is also accompanied by
metabolic change, with embryoid bodies and differenti-ating ESCs apparently less reliant on glucose uptake, with
mitochondrial activity increasing (Harvey et al., 2013;
Moussaieff et al., 2015). However,more recently, sequential
examination of metabolism during ESC differentiation
has identified differing requirements between lineages.
Consistent with a requirement for glycolysis to support
cell expansion, and with increasing glucose use by in vivo
derived post-implantationmouse and rat embryos (Clough
and Whittingham, 1983; Ellington, 1987), sustained
glycolysis is required to support neural differentiation
from ESCs (Lees et al., 2018). Combined, these data there-
fore highlight the ability of metabolites to regulate devel-
opment, ESC state, and differentiation, and support line-
age-specific metabolic requirements (Table 1).
Metabolic State of ASCs
The in vivo adult stem cell niche is characterized by low,
but physiological (<1%–8%) oxygen levels (Simsek et al.,
2010), which supports the high rates of glycolysis that are
essential for maintaining ASC quiescence and self-renewal
(Simsek et al., 2010). Nutrient availability in the medium,
particularly glutamine, has likewise emerged as a key
regulator of ASC survival and proliferation, by enhancing
mitochondrial function and stimulating mammalian
target of rapamycin complex 1 (mTOR complex) (Salabei
et al., 2015) as well as recruitment and hematopoietic
stem cell (HSC) specification (Oburoglu et al., 2014). Simi-
larly, selective metabolites, such as fructose-1,6-bisphos-
phate, phosphoenolpyruvic acid, and sodium oxalate,
have been shown to induce human mesenchymal stem
cell proliferation by increasing glycolytic metabolism
(Jeong et al., 2019). Interestingly, caloric restriction in
mice (20%–40% reduction in caloric intake) enhances
HSC quiescence and increases intestinal and skeletal
MuSC functionality, whereas a high-fat diet impairs HSC
and neuronal stem cell differentiation both in vitro and
in vivo (reviewed by Mana et al., 2017). Despite this exper-
imental evidence, it cannot be excluded that dietary inter-
ventions may result in altered growth factor signaling,
rather than merely changes in metabolites.
Fatty acid oxidation is also required for HSC mainte-
nance in the mouse, whereby loss of PPAR-d or inhibition
of mitochondrial fatty oxidation with etomoxir impairs
HSC maintenance, while exposure to the PPAR-d agonist
GW-501516 increases HSC maintenance (Ito et al., 2012).
Investigation of amino acid regulation of ASC self-renewal
is limited; however, valine and cysteine have recently been
reported to be indispensable for HSC proliferation in vitro,
whereas dietary valine is essential to the maintenance of
hematopoiesis in vivo (Taya et al., 2016).
In addition, in response to specific inductive signals
initiated by changes in ECM architecture and cytokine
levels, recruitment of ASCs away from the stem cell niche
has recently been shown to be mediated by nutrientStem Cell Reports j Vol. 13 j 573–589 j October 8, 2019 575
Table 1. Stage- and Cell State-Specific Metabolic Profiles of the
Embryo, and Embryonic and Adult Stem Cells
Cell State
Metabolite/Metabolic
Pathway Preference Reference
Oocyte and Preimplantation Embryo
Oocyte pyruvate (OXPHOS) Dumesic et al., 2015
Early cleavage-
stage embryo
[pyruvate
[lactate
Yglucose
[non-essential AA
Gardner and Harvey,
2015
First lineage
decision
proline? Tan et al., 2016
ICM Ypyruvate
Ylactate
[glucose
[non-essential AA
[essential AA
Gardner and Harvey,
2015
Hewitson and Leese,
1993
Tan et al., 2016
Trophectoderm [OXPHOS
Yglucose
Gardner and Harvey,
2015
Hewitson and Leese,
1993
Embryonic Stem Cell Self-Renewal
Naive mESCs Yglycolysis
[OXPHOS
glucose- and glutamine-
derived aKG
aKG can replace 2i/LIF
acetyl-CoA
Zhou et al., 2012
Carey et al., 2015
Tischler et al., 2019
Naive hESCs glycolysis and OXPHOS Gu et al., 2016
Serum/LIF mESCs glycolysis
threonine-derived SAM
Carey et al., 2015
Wang et al., 2009
Shyh-Chang et al.,
2013
Primed ESCs glycolysis
glucose-derived
acetyl-CoA
methionine-derived
SAM
Harvey et al., 2016a
Moussaieff et al., 2015
Shiraki et al., 2014
Embryo/ESC Differentiation
Embryoid bodies Yglycolysis
[mitochondrial
activity
Harvey et al., 2013
Moussaieff et al., 2015
mESC
differentiation
[proline
Ythreonine/SAM
aKG
Washington et al.,
2010
Arney and Fisher, 2004
TeSlaa et al., 2016
hESCs
differentiation
glycolysis/OXPHOS
(lineage dependent)
Ymethionine/SAM
aKG
Lees et al., 2018
Shiraki et al., 2014
TeSlaa et al., 2016
Table 1. Continued
Cell State
Metabolite/Metabolic
Pathway Preference Reference
Post-implantation
embryo
glycolysis Clough and
Whittingham, 1983
Ellington, 1987
Adult Stem Cell Self-Renewal/Proliferation
Cardiac
progenitors
glutamine
(mitochondrial
function)
Salabei et al., 2015
MSC glycolytic
intermediates
(FBP, PEP, OXA)
Jeong et al., 2019
HSCs fatty acid oxidation
valine, cysteine
Ito et al., 2012
Taya et al., 2016
MuSCs Ymitochondrial/
oxidative activity
fatty acid oxidation
Pala et al., 2018
Theret et al., 2017
Machado et al., 2017
Adult Stem Cell Recruitment and Specification
Cardiac
progenitors
glutamine
HSCs glutamine
mitochondrial
complex III activity
Oburoglu et al., 2014
Anso´ et al., 2017
MuSCs [OXPHOS
Yfatty acid oxidation
Pala et al., 2018
Theret et al., 2017
Gatta et al., 2017
Abbreviations: AA, amino acids; aKG, alpha-ketoglutarate; FBP, fructose
1,6-bisphosphate; PEP, phosphoenolpyruvic acid; OXA, sodium oxalate;
OXPHOS, oxidative phosphorylation; SAM, S-adenosylmethionine; 2i/LIF,
2 inhibitors (MEK and ERK)/leukemia inhibitory factor naive embryonic
stem cell culture medium.
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Reviewavailability and metabolic activity. Glucose and glutamine
use in particular have been shown to modulate HSC fate
and commitment both in vitro and in vivo, with glucose
metabolism regulating ASC activation and cell-cycle
entry (Oburoglu et al., 2014). Furthermore, loss of the
mitochondrial complex III subunit RISP (Rieske iron-sulfur
protein) in HSCs impairs differentiation in vivo, through a
reduction in the multipotent progenitor population and
decreased expression of HSC maintenance genes (Anso´
et al., 2017). Consequently, cellular metabolism is not a
passive bystander in stem cell maintenance or lineage
specification. Rather, metabolism regulates cell fate deci-
sions thatmay bias lineage specification and alter cell func-
tion (Table 1).
Metabolic Control of Muscle Stem Cells
Only recently has a well-defined metabolic roadmap for
MuSC biology been clarified. Isolated quiescent satellite
Stem Cell Reports
Reviewcells exhibit low oxygen consumption and mitochondrial
activity (Pala et al., 2018), and are characterized by a spe-
cific fatty acid oxidation signature (Machado et al., 2017).
Their progression to a proliferative state is characterized
by a burst of glycolysis, accompanied by higher fatty acid
metabolism and OXPHOS, increased mitochondrial
biogenesis and complexity, without a significant increase
in oxygen consumption (Pala et al., 2018; Ryall et al.,
2015), suggesting that other aspects of mitochondrial
biology may have regulatory functions. In contrast, differ-
entiation of satellite cells is associated with an increase in
OXPHOS (Pala et al., 2018).
This metabolic signature is further demonstrated by
decreased MuSC oxidative capacity as a result of 50 AMP-
activated protein kinase (AMPK) deletion, which correlates
with an increase in self-renewal and delays their differenti-
ation, compromising skeletal muscle regeneration (Theret
et al., 2017); an observation that links innate cell meta-
bolism with self-renewal. Conversely, a reduction in iso-
lated MuSC self-renewal occurs following pharmacological
inhibition of lactate dehydrogenase or by activating AMPK
with compound 991 (Theret et al., 2017). Inhibition of
fatty acid oxidation, which is a signature of the MuSC
quiescent state, using the 3-ketoacyl-CoA thiolase inhibi-
tor, trimetazidine, results inMuSC commitment and differ-
entiation (Gatta et al., 2017). Furthermore, treatment with
specific pharmacological inhibitors or inhibition of the
expression of rate-limiting enzymes for fatty acid oxidation
leads to altered differentiation of isolated MuSCs, indi-
cating that satellite cell commitment and differentiation
rely on peroxisomal, rather than mitochondrial fatty acid
oxidation (Pala et al., 2018). These studies therefore estab-
lish a reliance on fatty acid oxidation during satellite cell
quiescence, and a switch to OXPHOS and peroxisomal
oxidation as MuSCs progress through activation, prolifera-
tion, and differentiation.
The transition from quiescence to the activated state is
also tightly regulated by nutrient availability directly.
Culture of MuSCs in galactose-supplemented medium
forces cells to utilize OXPHOS, inhibiting self-renewal
and resulting in decreased number of MuSCs (Theret
et al., 2017). Moreover, lipid metabolism provides active
metabolites for satellite cells. The sphingolipid sphingo-
sine 1-phosphate modulates multiple key biological pro-
cesses in satellite cells, including cell proliferation,motility,
and differentiation, by activating the mitogen-activated
protein kinases/extracellular signal-regulated kinases and
AKT pathways, thereby promoting muscle regeneration
(Calise et al., 2012). Short-term caloric restriction also
induces an increase in MuSC number, associated with
higher oxidative activity and a concomitant decrease in
glycolysis, leading to enhanced muscle regeneration (Cer-
letti et al., 2012). Improvement in engraftment has beenobserved following MuSC transplantation into a mouse
previously subjected to caloric restriction (Cerletti et al.,
2012), suggesting that the nutrient microenvironment
may regulate satellite cell biology and engraftment (Table
1). Hence, metabolic reprogramming of MuSCs, or of their
niche, can be considered as a potential tool for improving
muscle regeneration and/or transplantation efficiency.
Interestingly, distinct satellite cell metabolic features
have enabled the identification of satellite cell sub-popula-
tions, with different proliferative and regenerative poten-
tial. In a rat model, two satellite cell sub-populations have
been distinguished within the same muscle, characterized
by specific metabolic profiles underpinned by differences
in mitochondrial redox state, respiratory CO2, and ATP
production. Consequently, highly proliferative clones
express higher levels of the glycolytic enzyme 6-phospho-
fructo-2-kinase/fructose-2,6-biphosphatase 3 and are
stem-like compared with low proliferative clones (Repele
et al., 2013). Therefore, different metabolic parameters
are likely a basis for intrinsic MuSC diversity, which may
be important for skeletal muscle to promptly respond to
external stimuli.
With age, MuSCs become dysfunctional, decreasing
the ability of skeletal muscle to successfully regenerate after
damage (Blau et al., 2015). The interplay between meta-
bolism and proteostasis maintains the reversible quies-
cence of satellite cells, which is lost in senescence. Pharma-
cological inhibition of mTOR with rapamycin improves
MuSC function in vivo, at least in part by increasing auto-
phagy and thereby promoting proteostasis (Garcı´a-Prat
et al., 2016). Interestingly, aged satellite cells are character-
ized by a reduction in most metabolic pathways, including
the TCA cycle, respiratory electron transport chain, and
mitochondrial fatty acid oxidation (Pala et al., 2018; Zhang
et al., 2016b). Contrastingly, glycolysis is an exception,
whereby aged satellite cells rely on glycolysis, rather than
OXPHOS, for ATP production (Pala et al., 2018). These
metabolic changes are consistent with mitochondrial
dysfunction and a decrease in NAD+ levels associated
with aging (Zhang et al., 2016b). Importantly, dietary sup-
plement with NAD+ increases senescent MuSC number
and the ability to regenerate muscles, by improving mito-
chondrial functions (Zhang et al., 2016b). In conclusion,
nutrients and metabolism are not merely energy sources
for the cell but finely define MuSC stage progression and
senescence, thereby affecting regenerative potential and
transplantation efficiency.
Epigenetics and Stem Cell Identity
Epigenetics is a key contributor to stemness, cell fate deter-
mination, and the maintenance of cell identity. Epigenetic
modifications regulate gene expression, without changing
the DNA sequence. These modifications represent anStem Cell Reports j Vol. 13 j 573–589 j October 8, 2019 577
Table 2. Stage-Specific Epigenetic Changes, Regulators, and Metabolites, Affecting Stem Cell Differentiation
Cell State Epigenetic Marks Biological Function Writers/Erasers Metabolites Cell Fate Transition Reference
Pluripotent low levels DNA
methylation
permissive chromatin
compaction
DNMT/TET1, 2, 3 SAM, aKG,
GlcNAc
favors undifferentiated
state
Clara Lopes Novo et al., 2018
Shyh-Chang et al., 2013
H3K4me3 transcriptional
activation
Wdr5
Ash2 (TrxG)/JARID1
KDM2B
SAM, GlcNAC favors self-renewal Liu et al., 2016
high levels
histone
acetylation
transcriptional
activation
HATs (PCAF, p300,
CBP, MOZ)/HDACs
SIRTs
acetyl-CoA
NAD+
favors pluripotency Battle et al., 2019
Differentiating H3K9me3 gene repression HMTs/JHDM aKG lineage commitment Meshorer et al., 2006
reduced histone
acetylation
gene repression HATs (PCAF, p300,
CBP, MOZ)/HDACs
SIRTs
acetyl-CoA
NAD+
lineage commitment Ryall et al., 2015
increased DNA
methylation
DNMTs/TET1, 2, 3 SAM, aKG,
GlcNAc
prevents alternative
fates and allow
differentiation
Chamberlain et al., 2008
H3K27me3 transcriptional
repression
PcG/UTX
JMJD3
SAM, GlcNAc prevents alternative
fates
O’Carroll et al., 2001
Abbreviations: Ash2, ASH2-like histone lysine methyltransferase complex subunit; aKG, a-ketoglutarate; CBP, CREB-binding protein; DNMTs, DNA methyl-
transferases; GlcNAc, N-acetylglucosamine; H3K4me3, histone H3 lysine 4 trimethylation; H3K9me3, histone H3 lysine 9 trimethylation; H3K27me3, his-
tone H3 lysine 27 trimethylation; HATs, histone acetyltransferases; HDACs, histone deacetylases; HMTs, histone methyltransferases; JARID1, histone de-
methylase; JMJD3, KDM1 lysine (K)-specific demethylase 6B; KDM2B, lysine demethylase 2B; MOZ, monocytic leukemia zinc finger protein; NAD+, oxidized
nicotinamide adenine dinucleotide; PCAF, P300/CBP-associated factor; SAM, S-adenosylmethionine; SIRTs, sirtuins; TET, ten-eleven translocation methyl-
cytosine dioxygenase; TrxG, Trithorax Group; UTX, lysine (K)-specific demethylase 6A; Wdr5, WD repeat domain 5.
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by DNA methylation, histone modifications, histone
variants, chromatin remodeling, and gene regulation by
non-coding RNAs (Atlasi and Stunnenberg, 2017). Intrinsic
and extrinsic cues influence the acquisition of daughter cell
identity during cell division, such that an epigenetic signa-
ture is gained as they progress toward lineage commitment
and differentiation. The exclusive signature of these modi-
fications allows sister cells sharing an identical genome to
harbor a cell-type-specific landscape which defines their
specific cell identity (Atlasi and Stunnenberg, 2017).
Epigenetic Control of ESCs
Progressive loss of pluripotency with differentiation of the
ICM results in the establishment of the three germ layers,
ultimately giving rise to more than 200 specialized cell
types of the mammalian body. In this specialization
process, the progressive decrease in cell differentiation
potential is accompanied by a restriction in epigenetic
plasticity, which delineates a cell-specific epigenetic
pattern in resultant somatic cells. Thus, during lineage
commitment and differentiation, a stage-specific epige-
netic landscape grants the transcriptional machinery
access to certain genes and defines a specific transcriptional
profile (Table 2). The gradual transcriptional and epigenetic
transition through different developmental stages in the578 Stem Cell Reports j Vol. 13 j 573–589 j October 8, 2019embryo can be largely recapitulated in vitro with ESC
differentiation.
The epigenetic landscape of undifferentiated ESCs fea-
tures a permissive chromatin configuration, with limited
DNA methylation and higher levels of histone acetylation
than lineage-restricted cells (Arney and Fisher, 2004; Mous-
saieff et al., 2015). In addition, mouse and human ESC
chromatin has been shown to be very dynamic, displaying
a higher exchange rate of architectural histone proteinsH1,
H2B, H3, and HP1a, when compared with differentiated
cells (Battle et al., 2019). Chromatin immunoprecipitation
assays in ESCs and in the developing embryo have shown
that regulatory regions of genes encoding key differentia-
tion-associated transcription factors are characterized by
the co-occurrence of the repressive histone modification,
H3K27me3, with smaller regions of the permissive modifi-
cation, H3K4me3, on the same allele (Bernstein et al.,
2006). These regions have been termed ‘‘bivalent’’ domains
and have been proposed to silence developmental regula-
tors while keeping them poised for future activation.
H3K4me3 is deposited by the chromatin factors Trithorax
Group proteins, favoring gene activation, and counteract-
ing the repressive action of Polycomb Group (PcG)
silencing. Significantly, in murine ESCs, knockdown of
the H3K4me3 regulators, Wdr5 and Ash2l, negatively
Stem Cell Reports
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2011; Wan et al., 2013). These features in chromatin archi-
tecture and histone modifications suggest that ESCs are
characterized by euchromatin, prone to transcriptional
activation.
H3K27me3 is found in promoters of developmental
genes in undifferentiated murine ESCs (Bernstein et al.,
2006) and is detectable from the 2- to the 16-cell-stage of
mouse embryo development, robustly increasing during
the early blastocyst stage (Liu et al., 2016). The
H3K27me3 mark is established by a protein complex
belonging to the PcG proteins, which play a pivotal role
in transcriptional repression during development. In un-
differentiated ESCs, developmental genes bound by the
pluripotency factors OCT4, NANOG, and SOX2 are tar-
geted by PcG repressive complexes (Lee et al., 2006).
Methylation of H3K27 is catalyzed by the PcG complex
PRC2, which is composed of three fundamental proteins:
embryonic ectoderm development (EED), suppressor of
zeste 12, and the histone methyltransferase (HMT)
enhancer of zeste homolog 2 (EZH2). PRC2 complex pro-
teins are not required for ESC pluripotency (Chamberlain
et al., 2008), but are indispensable for early mammalian
embryo development and the correct formation of the
three germ layers (O’Carroll et al., 2001). Indeed, knock-
down of the EED component of PRC2 results in increased
expression of certain lineage-related genes and aberrant
differentiation (Chamberlain et al., 2008). Overall, these
data highlight the key role played by the repressive mark
H3K27me3 in ESC biology.
The epigenetic plasticity of pluripotent stem cells is
progressively restricted during lineage commitment, with
differentiation accompanied by the loss of chromatin
accessibility, increased DNA methylation, and re-distribu-
tion of histone marks (Atlasi and Stunnenberg, 2017). As
differentiation proceeds, bivalent loci are resolved, losing
one of the two marks and becoming fully activated or sta-
bly silenced (Bernstein et al., 2006). Furthermore, hetero-
chromatic markers display a dispersed localization in mu-
rine ESCs, but are detected as concentrated distinct foci
in differentiated cells, with increased overall levels of
H3K9me3, a histone mark linked to gene repression, and
reduced levels of acetylated histones H3 and H4 (Meshorer
et al., 2006). In contrast, DNAmethylation and H3K27me3
are mutually exclusive at CpG islands in ESCs, where DNA
methylation antagonizes H3K27me3 deposition (Atlasi
and Stunnenberg, 2017). DNA methylation is catalyzed
by DNA methyltransferases (DNMTs), which add a methyl
group to the cytosine residue of CpG dinucleotides.
DNMT1 and DNMT3A/B depletion in ESCs blocks their
differentiation (Jackson et al., 2004), suggesting that regu-
lation of DNA methylation is essential for differentiation.
During ESC differentiation, DNMT3A is recruited to deace-tylated regulatory regions of pluripotency genes and con-
tributes to their transcriptional repression. In addition,
DNMT3A also methylates promoters at a subset of genes
that will be induced at later stages of differentiation. DNA
methylation at these sites will be removed during the
course of differentiation by the ten-eleven translocation
(TET) family of enzymes, which uses O2 to decarboxylate
a-ketoglutaric acid for the conversion of 5mC to 5hmC,
which is required for the formation of bivalent domains
at CpG islands of these developmental genes (Kong et al.,
2016). Therefore, the interplay between DNA methylation
and histonemodifications plays a key role in the regulation
of ESC self-renewal and differentiation.
As differentiation progresses during implantation in vivo,
chromatin accessibility becomes more selective, and
repressive epigenetic marks, such as H3K27me3, and
DNA methylation are deposited to prevent transcription
of regulators of alternative fates, or to avoid expression of
genes that would precociously lead to activation of other
differentiation pathways (Spivakov and Fisher, 2007).
Consequently, methylated DNA is thought to impair
recruitment of transcription factors toDNA and to promote
repressive chromatin through the association of methyl-
binding proteins (e.g., MeCP2 or MDB1) and histone de-
acetylases (HDACs) (Klose and Bird, 2006), thus affecting
chromatin accessibility and enhancer activity. During dif-
ferentiation and lineage commitment, transcription fac-
tors establish the specific gene expression program that
defines cell identity. Genome-wide studies have shown
that transcription factor binding at distal enhancers acti-
vates epigenetic events that result in increased transcrip-
tion. Enhancers are characterized by DNaseI hypersensitiv-
ity and enrichment in histone acetylases (HATs) p300/CBP,
H3K4me1 and H3K27ac marks, and RNA polymerase II
recruitment. More recently, a set of larger open chromatin
domains has been described in mouse and human ESCs,
denoted ‘‘super-enhancers.’’ These regulatory regions
control transcriptional activation of genes crucial for
stem cell behavior and cell identity, and are markedly re-
wired in the epiblast-derived stem cell state relative to
mouse and human ESCs (Clara Lopes Novo et al., 2018).
Global histone acetylation increases at genes that are tran-
scribed from day 0 to 5 during embryoid bodies formation
(Markowetz et al., 2010). Therefore, dynamic and
controlled regulation of the epigenetic landscape and
gene activation permits the acquisition of cell-type-specific
signatures to establish cell identity.
Overall, tight regulation of epigenetic events by chro-
matin modifiers shapes ESC plasticity and their changing
transcriptional program toward commitment and differ-
entiation. Identification of novel epigenetic marks and
their regulation, along with the role of less-characterized
modifications, such as GlcNAcylation, crotonylation,Stem Cell Reports j Vol. 13 j 573–589 j October 8, 2019 579
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understanding of the control of ESC self-renewal and
differentiation.
Epigenetic Control of ASCs
Within adult tissues, ASCs similarlymaintain stemness and
retain the potential to give rise to multiple differentiated
cell types, preserving tissue homeostasis, and allowing
tissue regeneration, through epigenetic modulation.
H3K27me3 profiles in ASCs regulate and maintain lineage
fidelity by preventing precocious induction of non-lineage-
specific differentiation genes, repressing muscle differenti-
ation. PRC2 loss of function affects stem cell proliferation
capacity and tissue regeneration in different ASC types,
such as neural and MuSCs (Pereira et al., 2010). The
inability to self-renew is attributed to the upregulation
of the Ink4a/Arf/Ink4b locus following PRC2 depletion
(Caretti et al., 2004; Juan et al., 2011), and consequent
cell-cycle arrest. EZH2 is expressed in MuSCs and its levels
decrease during differentiation. During differentiation of
MuSCs, when EZH2 levels decrease, myogenesis-related
genes are de-repressed (Caretti et al., 2004). In addition,
in response to tumor necrosis factor alpha, EZH2 interacts
with p38 and represses PAX7 expression during regenera-
tion, thus controlling the balance between proliferation
and differentiation of satellite cells (Caretti et al., 2011; Pal-
acios et al., 2010). These insights support a pivotal role for
PRC2 andH3K27me3 in tissue regeneration and regulation
of ASC self-renewal.
Although bivalent marks, indicative of a poised configu-
ration, are also found in ASCs as in ESCs, they co-occupy
fewer genes. In HSCs, many bivalent domains are resolved
during differentiation, but a subset of promoters maintain
bivalent marks after terminal differentiation (Abraham
et al., 2013). Nevertheless, bivalency is not exclusive to
stem or progenitor cells, because cells of restricted potency,
including T cells, fibroblasts, and adult tissues, can also ac-
quire de novo bivalency (Jadhav et al., 2016). Thus, biva-
lency may not simply represent a transient, plastic chro-
matin state during differentiation, but more likely a
condition present in most cell types, which may provide
the cell with a flexible chromatin configuration to respond
to a changing environment.
Recent findings also hint to a dynamic role for DNA
methylation in ASCs. At regulatory regions of develop-
mental genes, the interplay between DNMTs and TET en-
zymes defines dynamic alterations in DNA methylation,
which influence transcription factor association. For
instance, in blood and skin stem cells, regulatory regions
of differentiation-associated genes are methylated in pro-
genitor cells and become progressively demethylated dur-
ing cell differentiation (Bock et al., 2012). Similarly,
DNMT1 is highly expressed in the central nervous system
during embryogenesis and prevents neural stem cell differ-580 Stem Cell Reports j Vol. 13 j 573–589 j October 8, 2019entiation (Namihira et al., 2009). During neurogenesis,
DNMT3A methylates CpG islands of glial differentiation
genes, preventing their activation (Wu et al., 2010).
Conversely, histone acetylation also influences chro-
matin accessibility to transcriptional machinery in ASCs,
by modulating packed chromatin to a more relaxed state
and providing a permissive chromatin state for recruit-
ment of additional regulatory complexes. Loss of the ace-
tyltransferase monocytic leukemia zinc finger protein
severely reduces HSC lineage-committed progenitors and
B lineage cells, revealing a critical function in hematopoi-
esis (Katsumoto et al., 2006). Histone acetylation is
counterbalanced by the activity of HDACs, such as
HDAC and sirtuins (SIRT). Combined HDAC1/2 ablation
leads to severe hematopoietic failure (Wilting et al.,
2010). HDAC1/2 deletion in epidermal cells impairs tran-
scriptional repression by p63 on genes important inmain-
taining the proliferative potential of stem cells in the strat-
ified epithelia, leading to the failure of mature hair follicle
structures and epidermal proliferation and stratification
(LeBoeuf et al., 2010).
In MuSCs, SIRT1 mediates the H4K16 deacetylation of
MyoD regulatory regions, and SIRT1 ablation leads to pre-
mature differentiation in vitro and reduced regeneration
ability in vivo (Ryall et al., 2015). HDAC4 deletion, instead,
induces a derepression of the cyclin inhibitor p21 and
Sharp1 gene expression, thereby modulating MuSC prolif-
eration and differentiation in vitro, and muscle regenera-
tion in vivo (Marroncelli et al., 2018). Moreover, HDAC4
deletion in skeletal muscle inhibits MuSC proliferation
and differentiation via soluble factors (Renzini et al.,
2018). Thus, the interplay between HDACs and HATs or-
chestrates transcriptional regulation both in ESCs and in
adult tissue homeostasis.
Super-enhancers have been also described in ASCs,
including hair follicle stem cells, where they undergo pro-
found remodeling during lineage progression, resulting in
selective decommission or activation of a subset of these
regulatory regions (Adam et al., 2015). Overall, annotation
of super-enhancers through the characterization of histone
marks and transcription factor occupancy at these regulato-
ry regions will be a future development in the epigenetic
field to understand gene regulation in ESCs and ASCs and
the regulation of cell identity.
Our knowledge of the epigenetic landscape of ASCs has
improved significantly in the last decades, thanks to ad-
vances in genome technology and the development of
improved isolation methods for ASCs. In the future, we
expect to witness further progress toward characterization
of epigenetic changes that occur during differentiation
and ASC activation, particularly at the single-cell level, to
understand specific spatial and temporal epigenetic states
of ASCs in their niche.
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As well as providing cellular energy, dynamic and temporal
changes in metabolism directly affect nutrient availability
and metabolite production that lead to changes in gene
expression through alterations in epigenetic regulation.
Metabolic control of the enzymes that regulate chromatin
accessibility––e.g., HDACs, DNMTs, HMTs, or HATs––in-
volves the use of metabolites as cofactors, the availability
of which is strictly related to the energetic status of the
cell (Berger and Sassone-Corsi, 2016). This implies a direct
link between changes in metabolism and global conse-
quences on the stem cell and differentiating epigenome,
thereby influencing cell state, cell fate and identity, and
consequently cell function.
Themetabolic requirements of ESCs not only support the
provision of energy, but also provide intermediates that un-
derpin the pluripotent epigenetic landscape (Figure 1).
Most proliferating cells rely on the catabolism of glucose
to support biosynthetic requirements. Inhibition of glycol-
ysis, with 2-deoxyglucose, leads to ESC differentiation
(Carey et al., 2015) accompanied by decreased H3K9/
H3K27 acetylation (Moussaieff et al., 2015). High rates of
glycolysis drive the production of acetyl-CoA to modulate
acetylation (Moussaieff et al., 2015), supporting a role for
glycolytic activity in maintaining the pluripotent epige-
netic landscape. Indeed, acetyl-CoA production through
glycolysis rapidly decreases during differentiation of
pluripotent stem cells, and supplementation of differenti-
ating ESCs with acetate, a precursor of acetyl-CoA, is suffi-
cient to prevent differentiation-induced loss of H3K9 and
H3K27 acetylation, while fatty acid oxidation is relatively
low in human ESCs (Moussaieff et al., 2015).
Glucose-dependent glutamate production by naive
mouse ESCs similarly maintains low levels of histone
methylation through the generation of aKG, an essential
cofactor for both histone demethylases members of the
Jumonji family (JHDM) and TET enzymes, involved in
DNA demethylation (Figure 1). Glutamine deprivation
leads to increased H3K9, H3K27, H3K26, andH4K20 trime-
thylation in naive ESCs, which can be reversed through
supplementation with cell permeable aKG (Carey et al.,
2015). As cells transition from naive to primed pluripo-
tency, glucose-dependent glutamate production and intra-
cellular aKG levels decrease, accompanied by a concomi-
tant increase in histone methylation and a dependence
on glutamine (Carey et al., 2015). In contrast, human
ESC neural and endodermal differentiation is enhanced
by the inclusion of aKG during induction, as is mouse
differentiation induced by LIF withdrawal (TeSlaa et al.,
2016), indicates cell state-dependent nutrient require-
ments. Importantly, dysregulation in aKG levels leads to
deregulation of both DNA 50-hydroxymethylcytosine and
histone H3K9 tri-methylation levels in the regulatoryregions of pivotal transcription factors, hampering ESC dif-
ferentiation (Hwang et al., 2016), confirming that aKG can
be modulated to manipulate stem cell fate.
Threonine metabolism also contributes significantly to
the acetyl-CoA pool in mouse ESCs, but also to SAM syn-
thesis, which acts as a cofactor for both DNMTs and
HMTs (Shyh-Chang et al., 2013) (Figure 1). The reduction
in mouse ESC proliferation and increase in differentiation
observed following removal of threonine is accompanied
by an increase in the SAM/S-adenosylhomocysteine ratio
and a concomitant decrease in H3K4me3, which can be
rescued by supplementation with threonine, glycine, or
pyruvate (Shyh-Chang et al., 2013). Similarly, human
ESCs display a requirement for SAM to support self-
renewal, underpinned by regulation of methylation, via
the metabolome or the catabolism of methionine (Shiraki
et al., 2014; Sperber et al., 2015). Methionine deprivation
leads to a significant decrease in H3K4 trimethylation
and a reduction in global DNA methylation; however,
the loss of methylation following short-term (5 h) depriva-
tion could be abrogated by supplementation with SAM
(Shiraki et al., 2014). These data therefore suggest that
amino acids, including threonine andmethionine, are crit-
ical for maintaining mouse and human ESC self-renewal
via modulation of the pluripotent epigenetic landscape
(Shiraki et al., 2014; Wang et al., 2009). Likewise, differen-
tiation of ESCs induced by the amino acid proline are like-
wise associated with alterations in histone methylation
(Comes et al., 2013), further linking amino acid meta-
bolism to the regulation of the pluripotent and differenti-
ating ESC epigenome.
In addition to glycolytic activity, glucose flux contrib-
utes to the activity of the hexosamine biosynthetic
pathway. The hexosamine biosynthetic pathway is sensi-
tive to amino acid, fatty acid, and nucleotide metabolism,
and produces uridine diphosphate N-acetylglucosamine, a
substrate necessary for the addition of O-linked-N-acetyl-
glucosamine (O-GlcNAc) to serine or threonine residues
of intracellular proteins, catalyzed by O-GlcNAc trans-
ferase (OGT) (Hanover et al., 2012). Indeed, reduced
glucose availability or inhibition of O-GlcNAcylation
leads to an impairment in ESC self-renewal and increased
expression of several markers of differentiation, whereas
increased global O-GlcNAc levels inhibits ESC differentia-
tion (Jang et al., 2012). Such nutrient-sensitive post-trans-
lational histone modification further links metabolic state
to stem cell fate via epigenetic regulation of gene tran-
scription. Although OGT can associate with the TET pro-
tein family, the PRC2 complex is required for the correct
cellular distribution of O-GlcNAcylation in mouse ESCs
and to maintain normal OGT levels (Myers et al., 2011).
Thus, O-GlcNAcylation likely modulates chromatin
compaction and gene transcription either positively orStem Cell Reports j Vol. 13 j 573–589 j October 8, 2019 581
Figure 1. Metabolism Finely Regulates Chromatin Structure and Gene Transcription
Glycolysis provides intermediates such as fructose-6-phosphate (Fructose 6-P), 3-phosphoglycerate (3-P-Glycerate), and pyruvate, which
trigger the hexosamine biosynthetic pathway, the one-carbon cycle, and the TCA cycle, respectively. The hexosamine biosynthetic
pathway generates uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), an N-acetylglucosamine (GlcNAc) donor for addition of
O-linked N-acetylglucosamine (O-GlcNAc) to histone proteins. The one-carbon cycle produces S-adenosylmethionine (SAM), a donor for
methylation of both DNA and histone proteins. The TCA cycle generates a-ketoglutarate (aKG), the main cofactor for both the histone
demethylases members of the Jumonji family (JHDM) and TET enzymes, involved in DNA methylation. In addition, the TCA cycle generates
citrate, which is converted by ATP-citrate lyase (ACL) to acetyl-CoA, which acts as an acyl donor for histone acetylation. Acetyl-CoA can
derive from either glycolysis or fatty acid oxidation. NAD+ is a main cofactor for SIRT1-mediated histone deacetylation. Intracellular NAD+
levels are determined by glycolysis and oxidative phosphorylation. SIRT1 catalyzes the NAD+-dependent deacetylation of target proteins,
which are regulated by this reversible lysine modification. During deacetylation, NAD+ is converted to nicotinamide (NAM) and the ribose
accepts the acetyl group from substrate to produce O-acetyl-ADP-ribose (OAADPr). Red dots, methyl groups; green dots, acetyl groups.
(legend continued on next page)
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associated (Figure 1).
Metabolites have also been shown to affect epigenetics
and ASC behavior. As in ESCs, acetyl-CoA is an important
acetyl donor for histone acetylation in ASCs. By regulating
the availability of acetyl-CoA, the enzyme ATP-citrate lyase
alters histone H3 acetylation status in the MyoD locus,
promoting MuSC differentiation (Das et al., 2017). Simi-
larly, NAD+, a co-substrate for SIRTs, regulates acetylation
(Figure 1). During the exit from the quiescence state, a
decrease in cellular NAD+ levels leads to an increase in
the acetylation of H4K16 and contributes to the induction
of the myogenic cell fate (Ryall et al., 2015). In response to
high glucose, for instance, SIRT1 represses the Hes-1 pro-
moter, thereby impairing neural stem cell proliferation.
Conversely, upon caloric restriction, the transcription
factor cAMP response element-binding protein replaces
SIRT1 on Hes-1 promoter and activates neural stem cell
proliferation (Fusco et al., 2016). Considering the aging-
dependent decline in NAD+ cellular levels (Imai and Guar-
ente, 2014), the epigenome may be directly and globally
affected by this metabolic change.While the links between
metabolism and the epigenome are still being elucidated,
because aging induces both epigenetic and metabolic
changes in stem cells, it will be important to delineate their
intimate connections to better understand the molecular
mechanisms underlying aging.
Flavin adenine dinucleotide (FAD), a redox coenzyme
derived from the vitamin riboflavin (B2), is involved in
several important enzymatic reactions in metabolism.
FAD can also influence epigenetic changes via lysine-spe-
cific demethylase 1 (LSD1), a FAD-dependent histone 3 de-
methylase that suppresses gene expression by converting
dimethylated H3K4 to mono- and unmethylated H3K4
(Shi et al., 2004). Increasing intracellular FAD has been
shown to promote neural stem cell differentiation by
increasing LSD1 nuclear localization and enzymatic activ-
ity (Hirano and Namihira, 2017).
In addition to the significant evidence that metabolites
directly influence epigenetics, an inverse relationship has
also been demonstrated, such that epigenetic factors regu-
late stem cell metabolism and fate. For instance, inactiva-
tion of SIRT1 in neural stem cells induces oligodendrocyte
progenitor expansion and altered expression of metabolic
genes (Rafalski et al., 2013). In HSCs, SIRT7 is important
for maintaining their regenerative capacity, by repressingACL, ATP-citrate lyase; ADP, adenosine diphosphate; aKG, a-ketoglut
FAD, flavin adenine dinucleotide; GlcNAc, N-acetylglucosamine; H
methyltransferase; JHDM, Jumonji domain-containing histone demet
reduced nicotinamide adenine dinucleotide; NAM, nicotinamide; OAA
OGT, O-linked b-N-acetylglucosamine transferase; SAH, S-adenosylhom
eleven translocation methylcytosine dioxygenase; TDH, threonine dethe nuclear respiratory factor 1-dependentmetabolic genes
and the mitochondrial unfolded protein response (Mohrin
et al., 2015).
Further investigation focusing on how metabolism and
nutrient availability affects more recently identified his-
tone post-translational modifications (such as crotonyla-
tion, propionylation, or succinylation), as well as other
acetylation/methylation residues, and linking these epige-
netic modifications to changes in stem cell is needed.
Intergenerational Epigenetic Modifications Associated with
Changes in Metabolism
Changes in nutrient intake have clearly been associated
with changes in the epigenome in different species
(Zhang and Kutateladze, 2018), with some alterations in-
herited by subsequent generations (Skvortsova et al.,
2018). Indeed, metabolic challenges might affect either
the epigenome of parental gametes or the development
of primordial germ cells, thereby influencing next
generations.
DNA methylation has been extensively studied as a
transgenerational epigenetic mark, owing to its relative sta-
bility. In mice, starvation of pregnant F0 females results in
metabolic phenotypes with altered DNA methylation at
discrete loci in adult F1 sperm, which leads to significantly
altered transcriptional profiles in F2 genes involved in
metabolic functions (Radford et al., 2014). Intrauterine
growth restriction has also been associatedwith F2 changes
in blastocyst gene expression andnutrient utilization (Mas-
ter et al., 2015), whichmanifest asmetabolic disease in sub-
sequent offspring (Master et al., 2014). In humans, defi-
ciency in nutrients during early gestation impacts DNA
methylation of the offspring (Heijmans et al., 2008). More-
over, small RNAs have been recently implicated in the
intergenerational transmission of metabolic phenotypes
in mammals. Indeed, small tRNA fragments inherited
from sperm of fathers fed either a low-protein or high-fat
diet, or those from obese, prediabetic fathers, mediate the
repression of metabolic genes in mouse embryos (Cropley
et al., 2016; St. John et al., 2019). Significantly, autologous
mitochondrial supplementation has recently been shown
to alter weight gain and gene expression in F1-F3 genera-
tions, accompanied by lesions of, and thickening to, the
connective tissue of the atria-ventricular valves in several
F1 and F2 mice (Portela and Esteller, 2010) suggesting
that altered metabolism may be in part responsible for
these effects.arate; ATP, adenosine triphosphate; DNMT, DNA methyltransferase;
AT, histone acetyltransferase; HCY, homocysteine; HMT, histone
hylase; NAD+, oxidized nicotinamide adenine dinucleotide; NADH,
DPr, O-acetyl-ADP-ribose; O-GlcNAc, O-linked N-acetylglucosamine;
ocysteine; SAM, S-adenosylmethionine; SIRT1, sirtuin 1; TET, ten-
hydrogenase; THF, tetrahydrofolate.
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bolism in transgenerational epigenetic inheritance, no
studies have examined specific changes in individual co-
substrates as regulators of chromatin-modifying proteins
beyond the F1 generation. In addition, it is difficult to
demonstrate a direct link between changes in the germ
line epigenome and regulation of gene expression of the
offspring (Lappalainen and Greally, 2017), or to exclude
that the differences in DNA sequence among individuals
may contribute to the inheritance of epigenetic states (Eck-
ersley-Maslin et al., 2018). However, because the epige-
nome inherited from the gametes is heavily programmed
during embryo development (Eckersley-Maslin et al.,
2018), how the environment affects disease risk across gen-
erations may nonetheless be linked with metabolic regula-
tion of the epigenome and highlights the need for further
studies to assess the transgenerational impact(s) of individ-
ual metabolic perturbations at a systems biology level.
Implications for Stem Cell Application and Disease
Models
The continued ability of stemcells to generate representative
cell types is viewed as indicative of cell health. Indeed, stem
cellshavebeennotedashavingremarkableplasticitywith re-
gard to their surrounding microenvironment in vitro, sup-
porting their differentiation into many specified cell types.
However, subtle changes in nutrient availability and me-
dium composition can impact on pathway flux that result
in an altered metabolic state and consequently epigenetic
state (Zhang et al., 2016a). Although cells must balance cell
stability and flexibility to respond to external stimuli, meta-
bolic plasticity, however, comes at a price. Numerous studies
have demonstrated a link between non-physiological
nutrient availability and post-implantation embryo survival
and development, as well as transgenerational impacts of
diet.Consequently,perturbationspersist, andoftenmanifest
post-implantation and, in the adult, mediated through per-
manent changes to the epigenome. Indeed, exposure of pre-
implantation embryos to altered nutrient availability for
even 6 h is sufficient to induce a loss in implantation poten-
tial (Lane andGardner, 1998), highlighting the sensitivity of
earlydevelopment tonutrient availability. Inanextensionof
this, perturbations in nutrient availability within the in vitro
and in vivo stem cell niche will likely have consequences not
only for self-renewal, recruitment, and differentiation, but
may program cell function and viability through modula-
tion of the epigenetic landscape, leading to dysfunction
and disease (Moresi et al., 2015).
Our evolving understanding of the link between meta-
bolic state and the epigenome therefore raises significant
questions as to whether in vitro manipulation of nutrient
availability induces perturbations in downstream cell func-
tion and health, a concern that is particularly relevant for584 Stem Cell Reports j Vol. 13 j 573–589 j October 8, 2019the efficacy and safety of cell transplantation and disease
models. Similarly, whether and/or how the in vivo meta-
bolic environment hinders cell integration following trans-
plantation, beyond our understanding of ischemia, is likely
to lead to metabolic supplements as adjuncts to cell ther-
apy. Plausibly, sub-optimal nutrient formulations may un-
derpin poor stem cell transplantation retention and inte-
gration to date. Furthermore, metabolic and epigenetic
factors may have developmental, stage- and tissue-specific
functions, and the range of consequences of their disrup-
tion may vary depending on cellular activity. Whether
modulation of the culture environment is therefore
capable of expanding the number of cell types that can
be differentiated remains to be explored. Such insights
will assist in the design of more physiological media
formulations and culture protocols to support long-term
cell viability. One valuable and easily implemented starting
point thatmust be considered is the incubator atmosphere.
Although often viewed as innocuous and insignificant, the
metabolite oxygen has been shown to alter the epigenetic
landscape (Lamadema et al., 2019; Lees et al., 2019). How-
ever, given oxygen significantly alters nutrient use, partic-
ularly glycolysis (Harvey et al., 2016b; Lees et al., 2019) im-
pacting on the availability of metabolites such as aKG and
acetyl-CoA, the effects of modulating the availability
of additional metabolites, including those described above
that regulate stem cell state and epigenetics, in combina-
tion with physiological oxygen conditions is likely to
further alter differentiation kinetics and cell fate decisions.
The reluctance to change to a physiological atmosphere,
while concerning, is, however, impeded by the decades of
scientific work and understanding that have relied on cells
surviving atmospheric oxygen culture (undoubtedly a se-
lection), and apparent ‘‘plasticity’’ of cells to grow and
differentiate under such sub-optimal conditions. However,
as the aspirations for the clinical use of stem cells become a
reality, the question becomes ‘‘at what cost’’ do we ignore
the elephant in the room and risk destroying the future
of stem cell translation should cells start to fail?
Conclusions
Cell metabolism intrinsically regulates the molecular
signature of stem cells, affecting stemness and differentia-
tion. Energetic state directly affects the epigenetic regula-
tors that modulate gene transcription by altering the avail-
ability of cellular metabolites, pivotal cofactors of many
chromatin remodeling factors, such as histone methyl-
transferases or acetylases. Since the local energetic reservoir
regulates stem cell identity, metabolic reprogramming of
stem cells should be considered as a potent tool for
improving tissue regeneration.
There is clear need to understand the impact of in vitro
culture on the interplay between nutrient availability and
Stem Cell Reports
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to the impact of nutrient availability on both long-term
stem cellmaintenance and expansion, and during differen-
tiation, particularly given often limited examination of cell
physiology of endpoint cell types, as well as the perma-
nence or reversibility of the epigenetic responses. More-
over, from a therapeutic perspective, additional studies
are necessary to better understand themetabolic and epige-
netic alterations that cause, rather than correlate with, dis-
eases, and those which support tissue regeneration. The
consideration of nutrient regulation of cell fate and func-
tion is of particular importance given emerging clinical
trials exploring the use of in vitro cultured and expanded
cells differentiated from pluripotent and ASCs, and their
engraftment potential into a damaged niche. Plausibly,
strategies to enhance regenerative therapies will need to
consider nutrient modifications in parallel to ensure not
only cell survival and engraftment, but also support the es-
tablishing epigenetic landscape.
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